Abstract:Substance use disorders (SUDs) induce widespread molecular dysregulation in the nucleus accumbens (NAc), a brain region pivotal for coordinating motivation and reward. These molecular changes are thought to support lasting neural and behavioral disturbances that promote drug-seeking in addiction. However, different drug classes exert unique influences on neural circuits, cell types, physiology, and gene expression despite the overlapping symptomatology of SUDs. To better understand common and divergent molecular mechanisms governing SUD pathology, our goal was to survey cell-type-specific restructuring of the NAc transcriptional landscape in after psychostimulant or opioid exposure. We combined fluorescence-activated nuclei sorting and RNA sequencing to profile NAc D1 and D2 medium spiny neurons (MSNs) across cocaine and morphine exposure paradigms, including initial exposure, prolonged withdrawal after repeated exposure, and re-exposure post-withdrawal. Our analyses reveal that D1 MSNs display many convergent transcriptional responses across drug classes during exposure, whereas D2 MSNs manifest mostly divergent responses between cocaine and morphine, with morphine causing more adaptations in this cell type. Utilizing multiscale embedded gene co-expression network analysis (MEGENA), we discerned transcriptional regulatory networks subserving biological functions shared between cocaine and morphine. We observed largely integrative engagement of overlapping gene networks across drug classes in D1 MSNs, but opposite regulation of key D2 networks, highlighting potential therapeutic gene network targets within MSNs. These studies establish a landmark, cell-type-specific atlas of transcriptional regulation induced by cocaine and by morphine that can serve as a foundation for future studies towards mechanistic understanding of SUDs. Our findings, and future work leveraging this dataset, will pave the way for the development of targeted therapeutic interventions, addressing the urgent need for more effective treatments for cocaine use disorder and enhancing the existing strategies for opioid use disorder.

Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users

Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users

Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study

Volumetric abnormalities of grey matter in methamphetamine dependent patients

Cognitive Function and Nigrostriatal Markers in Abstinent Methamphetamine Abusers

Abnormal static and dynamic amplitude of low-frequency fluctuations in multiple brain regions of methamphetamine abstainers

Compulsive Drug-Taking is Associated with Habenula–frontal Cortex Connectivity

Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.

Compulsive Drug Use is Associated with Imbalance of Orbitofrontal- and Prelimbic-Striatal Circuits in Punishment-Resistant Individuals

Alterations in the brain functional network of abstinent male individuals with methamphetamine use disorder

Hereditary and cortical morphological biomarker of sensitivity to reward in short-term withdrawal methamphetamine abusers

Comparison of striatal dopamine transporter levels in chronic heroin‐dependent and methamphetamine‐dependent subjects

Influence of Compulsivity of Drug Abuse on Dopaminergic Modulation of Attentional Bias in Stimulant Dependence.

Brain Glucose Metabolism and Dopamine Transporters Change in Addiction and Environmental Cue-Induced Memory

Methamphetamine Activates Reward Circuitry in Drug Naïve Human Subjects

Hypovolaemic shock after anthelmintic treatment of canine angiostrongylosis.

PET Imaging of Dopamine Transporter and Drug Craving During Methadone Maintenance Treatment and after Prolonged Abstinence in Heroin Users.